Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
tisagenlecleucel
MeSH Supplementary Concept Data 2025
Details
Concepts
MeSH Supplementary
tisagenlecleucel
Unique ID
C000626284
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000626284
Entry Term(s)
CTL019
KYMRIAH
Pharm Action
Antineoplastic Agents, Immunological
Registry Numbers
Q6C9WHR03O
Heading Mapped to
*Receptors, Antigen, T-Cell
Frequency
200
Note
anti-CD19 chimeric antigen receptor (
CAR
) T-cell therapy for treatment of B-Cell lymphoblastic leukemia
Source
N Engl J Med. 2018 Feb 1;378(5)439-448
Date of Entry
2018/02/21
Revision Date
2021/11/05
Expand All
Collapse All
tisagenlecleucel
Preferred
Concept UI
M000641063
Registry Numbers
Q6C9WHR03O
Terms
tisagenlecleucel
Preferred Term
Term UI
T000940514
Date
02/21/2018
LexicalTag
NON
ThesaurusID
NLM (2017)
CTL019
Broader
Concept UI
M000648076
Terms
CTL019
Preferred Term
Term UI
T000953601
Date
03/26/2019
LexicalTag
LAB
ThesaurusID
NLM (2019)
KYMRIAH
Related
Concept UI
M000648352
Terms
KYMRIAH
Preferred Term
Term UI
T000940513
Date
02/21/2018
LexicalTag
NON
ThesaurusID
NLM (2017)
page delivered in 0.003s